University of Concepcion, Chile   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Concepcion Chile (1919)

Organization Overview

First Clinical Trial
2018
NCT05264467
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Centro de Vida Saludable, Universidad de Concepción | Universidad de Concepcion | Universidad de Concepción | University of Concepcion, Chile

Active Ingredients

Drugs in Phase 3 Trials (1)

platelet rich fibrin (1 trial)

Drugs in Phase 2 Trials (1)

acetylcysteine (mucomyst) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cocaine-Related Disorders (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2